Logo Background RSS

Advertisement

Roche goes hostile with $42bn Genentech bid

  • Written by admin | No Comments Comments
    Last Updated: January 31st, 2009

    … through a combination of cash, commercial paper, bonds and bank finance, signals Roche’s confidence in … to raise support in spite of the credit crunch, and its willingness to exploit falling equity … would begin external fundraising by approaching the bond market. Roche is being advised by Greenhill, …

Advertisement

Leave a Comment